Ionis Pharmaceuticals | IONS - Ebitda


Ionis Pharmaceuticals reported $-200.02M in EBITDA for its fiscal quarter ending in December of 2025.





Ebitda Change Date
Agios Pharmaceuticals USD -120.31M 4.82M Dec/2025
Alnylam Pharmaceuticals USD 145.22M 236.56M Dec/2025
Arrowhead Research USD 57.17M 7.03M Dec/2025
Astellas Pharma JPY 98.93B 84.75B Mar/2026
BioCryst Pharmaceuticals USD 51.7M 30.14M Sep/2025
BioMarin Pharmaceutical USD 146.05M 170.22M Mar/2026
Celltrion KRW 17.79B 356.77B Dec/2025
Cspc Pharmaceutical CNY 2.19B 21.88M Dec/2024
Deva Holding AS TRY 882.9M 201.7M Sep/2023
Divis Laboratories Ltd INR 9.34B 440M Mar/2026
Esperion Therapeutics USD -9.93M 24.99M Sep/2025
Exelixis USD 258.29M 15.43M Mar/2026
Halozyme Therapeutics USD 219.57M 197.66M Mar/2026
Ionis Pharmaceuticals USD -200.02M 42.89M Dec/2025
Kangmei Pharma CNY -12.72M 30.02M Mar/2026
Knight Therapeutics CAD 24.45M 3.46M Dec/2025
Laboratorios Farma EUR 34.94M 102.95M Jun/2025
Malin Corporation EUR -1.1M 200K Dec/2024
Medical Developments International AUD 1.78M 3.78M Dec/2024
Moderna USD -790M 582M Dec/2025
Nektar Therapeutics USD -31.81M 70K Sep/2023
Neuren Pharmaceuticals AUD 11.14M 165.56M Dec/2025
Neurocrine Biosciences USD 193.3M 25.1M Mar/2026
Novartis USD 5.3B 530M Mar/2026
Omeros USD -47.96M 7.39M Sep/2023
OPKO Health USD 75.53M 144.7M Sep/2025
Organigram Holdings CAD 5.26M 884K Dec/2025
Pfizer USD 5.99B 5.23B Mar/2026
Pharma Mar EUR 2.71M 42.25M Mar/2026
PTC Therapeutics USD -70.99M 91.62M Dec/2025
Qiagen NV USD 249.69M 56.53M Dec/2025
Regeneron Pharmaceuticals USD 1.2B 718.4M Dec/2025
Roche Holding CHF 12.68B 2.36B Jun/2024
Sarepta Therapeutics USD -252.2M 84.16M Dec/2025
Sartorius EUR 267.3M 10.1M Mar/2026
Sino Biopharmaceutical CNY 2.59B 1.57B Dec/2024
Tilray USD 8.36M 1.82M Sep/2025
Ultragenyx Pharmaceutical USD -99.43M 57.35M Dec/2025
Vertex Pharmaceuticals USD 1.19B 195.3M Mar/2026
Zealand Pharma A/S -727.47M 285.54M Dec/2025
Zhangzhou Pientzehuang Pharmaceutical CNY 882.7M 351.1M Mar/2026